首页> 外文期刊>Clinical Pharmacology and Therapeutics >Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.
【24h】

Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population.

机译:CYP2D6 * 10和* 14等位基因的频率及其对CYP2D6代谢活性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

To study the frequency of CYP2D6(*)10 and (*)14 alleles in a healthy Chinese population, and the influence of these two alleles on the metabolic activity of CYP2D6. CYP2D6(*)10 and (*)14 genotypes of 295 healthy Chinese subjects were determined using a tetra-primer method and allele-specific amplification. CYP2D6 phenotypes of 131 subjects were determined using dextramethorphan as probe drug. There were 10 subjects with a (*)14 allele, including one homozygous for (*)14. The gene frequency of (*)10 and (*)14 alleles were 55.8 and 1.8%, respectively. The metabolic ratio (MR) of dextramethorphan in 131 subjects was 0.032+/-0.106. The MR of (*)1/(*)1, (*)1/(*)10, (*)10/(*)10, (*)1/(*)14, (*)10/(*)14, and (*)14/(*)14 groups were 0.007+/-0.012, 0.009+/-0.010, 0.042+/-0.029, 0.093, 0.11, and 1.186, respectively. The MR of subjects with (*)14 allele was higher than those of (*)1/(*)1, (*)1/(*)10, or (*)10/(*)10 groups (P<0.001). The CYP2D6(*)10 and (*)14 alleles have substantial impact on the metabolic activity of CYP2D6, and the CYP2D6(*)14 allele may be the cause of the poor metabolizer phenotype in Chinese subjects.
机译:研究健康中国人群中CYP2D6(*)10和(*)14等位基因的频率,以及这两个等位基因对CYP2D6代谢活性的影响。使用四引物法和等位基因特异性扩增法测定了295名健康中国人的CYP2D6(*)10和(*)14基因型。使用右美沙芬作为探针药物确定了131位受试者的CYP2D6表型。有10名受试者具有(*)14等位基因,包括一个纯合子(*)14。 (*)10和(*)14等位基因的基因频率分别为55.8和1.8%。 131名受试者中右美沙芬的代谢率(MR)为0.032 +/- 0.106。 (*)1 /(*)1,(*)1 /(*)10,(*)10 /(*)10,(*)1 /(*)14,(*)10 /(* )14和(*)14 /(*)14组分别为0.007 +/- 0.012、0.009 +/- 0.010、0.042 +/- 0.029、0.093、0.11和1.186。具有(*)14个等位基因的受试者的MR高于(*)1 /(*)1,(*)1 /(*)10或(*)10 /(*)10组的受试者的MR(P <0.001 )。 CYP2D6(*)10和(*)14等位基因对CYP2D6的代谢活性具有实质性影响,而CYP2D6(*)14等位基因可能是中国受试者代谢表型不良的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号